Welcome to kongre.net

CD

SummitIn personPast event

4th Covalent Drug Discovery & Development Summit

Hosted by Hanson Wade

20 – 22 October 2026
Hampton Inn Boston Seaport District, Boston, United States of America
Health SciencesPharmacy & Pharmaceutical Sciences

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Welcome to kongre.net

Official website

Programme

Published

25 sessions across 3 days

22 speakers

Browse programme

Registration

Event has ended

Registration is handled by the organiser

Fees are listed on this page

View registration details

Key facts

4th Covalent Drug Discovery & Development Summit is a summit held 20 – 22 October 2026 in Hampton Inn Boston Seaport District, Boston, United States of America, organised by Hanson Wade.

Dates:: 20 – 22 October 2026
Format:: In person
Venue:: Hampton Inn Boston Seaport District, Boston, United States of America
Subjects:: Pharmacy & Pharmaceutical Sciences
Organiser:: Hanson Wade
Official website:: covalent-drug-discovery.com

Returning for its 4th year, the Covalent Drug Discovery & Development Summit is an industry forum dedicated entirely to advancing covalent therapeutics end-to-end, from early discovery through to IND and early clinical development. Organized by Hanson Wade, the event takes place from October 20-22, 2026, in Boston, MA. It unites international biopharma leaders, researchers, and academic experts to deliver data-driven case studies, translational strategies, and insights into overcoming selectivity, safety, and PK/PD challenges in covalent drug development.

Conference theme

Advancing Novel Covalent Therapies to the Clinic

Programme highlights

View full programme

Tue, 20 Oct 2026Workshop A: Transforming Covalent Warhead Design by Aligning Chemistry with Developability & Translational Expectations to Accelerate Progression Towards INDWorkshop2 sessions this day
Wed, 21 Oct 2026Chair’s Opening RemarksPlenary13 sessions this day
Thu, 22 Oct 2026Chair’s Closing RemarksPlenary10 sessions this day

Speakers

View all 22 speakers

Weixue Wang
Antares Therapeutics
Workshop B: Optimizing Translational Readiness in Covalent Programs Through Robust Integration of kinact/KI & Selectivity Data
Jacob Stuckey
Flare Therapeutics
Workshop A: Transforming Covalent Warhead Design by Aligning Chemistry with Developability & Translational Expectations to Accelerate Progression Towards IND
Jack Sloane
Bristol Myers Squibb
Unlocking Novel Covalent Reactivity in KRAS G12C Through Innovative Warhead Design
Mu-Sen Liu
Tango Therapeutics
Mass Spectrometry-Based Kinetic & Site-Specific Profiling of Covalent Inhibitors Targeting VRK1
Jianwei (John) Che
Dana-Farber Cancer Institute
Targeting A Non-Traditional Residue to Reprogram E3 Ligase Function & Degradation Profiles
Chris Haggard
Axiom Therapeutics
Accelerating Covalent Drug Design by Improving Prediction of Binding Reactivity & Reducing Experimental Iteration Through Physics-Based & Data-Driven Models
Jay Duffner
Frontier Medicines
Strategic Deployment of Kinetic Assay Technologies to Accelerate Covalent Drug Discovery
David Anderson
Aclaris Therapeutics
Workshop B: Optimizing Translational Readiness in Covalent Programs Through Robust Integration of kinact/KI & Selectivity Data

Venue & travel Hampton Inn Boston Seaport DistrictBoston, United States of AmericaVenue details About the organiser Hanson Wade4 more events from this organiserOrganiser profile Who is going? See who attended this eventSee who is going

Organiser and contact

Host organisation

Hanson Wade 4 more events from Hanson Wade

Contact

Event secretary:: Deeya Gurung
Email:: [email protected]

Advertisement

Related events